{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:19:46Z","timestamp":1787170786966,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["351041"],"award-info":[{"award-number":["351041"]}]},{"name":"Australian National Health and Medical Research Council","award":["510448"],"award-info":[{"award-number":["510448"]}]},{"name":"Australian National Health and Medical Research Council","award":["1052979"],"award-info":[{"award-number":["1052979"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.vaccine.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T20:16:55Z","timestamp":1473970615000},"page":"5251-5261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype"],"prefix":"10.1016","volume":"34","author":[{"given":"C. Mee Ling","family":"Munier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"van Bockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheilajen","family":"Alcantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Denyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tscharke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Zaunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.09.009_b0005","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","article-title":"Characterization of CD4(+) CTLs ex vivo","volume":"168","author":"Appay","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0010","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood-2003-08-2765","article-title":"Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection","volume":"103","author":"Zaunders","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2016.09.009_b0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003165","article-title":"HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome","volume":"4","author":"Soghoian","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.09.009_b0020","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1128\/JVI.00438-15","article-title":"Cooperativity of HIV-specific cytolytic CD4 T cells and CD8 T cells in control of HIV viremia","volume":"89","author":"Johnson","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0025","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M","article-title":"CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens","volume":"31","author":"Suni","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0030","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4049\/jimmunol.173.3.1834","article-title":"Emergence of a CD4+CD28-granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection","volume":"173","author":"van Leeuwen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0035","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.169.4.2172","article-title":"Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope","volume":"169","author":"Omiya","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","article-title":"Cytotoxic CD4 T cells in viral hepatitis","volume":"13","author":"Aslan","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2016.09.009_b0045","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1128\/JVI.79.10.5988-5995.2005","article-title":"Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio","volume":"79","author":"Wahid","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0050","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","article-title":"The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope","volume":"188","author":"de Souza","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0055","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1073\/pnas.0813106106","article-title":"Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection","volume":"106","author":"Sacha","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.09.009_b0060","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to Vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0065","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.1128\/JVI.02670-05","article-title":"CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to Vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells","volume":"80","author":"Zaunders","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0070","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1128\/JVI.00249-06","article-title":"Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection","volume":"80","author":"Zaunders","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2009.03.013","article-title":"A culture amplified multi-parametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses","volume":"345","author":"Munier","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.09.009_b0080","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.4049\/jimmunol.0803548","article-title":"High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)","volume":"183","author":"Zaunders","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0085","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1093\/nar\/29.5.e29","article-title":"Quantitative analysis of mRNA amplification by in vitro transcription","volume":"29","author":"Baugh","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2016.09.009_b0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2016.09.009_b0095","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1093\/bioinformatics\/bth449","article-title":"LimmaGUI: a graphical user interface for linear modeling of microarray data","volume":"20","author":"Wettenhall","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.09.009_b0100","first-page":"66","article-title":"Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region","volume":"1","author":"Suzuki","year":"2005","journal-title":"J RNAi Gene Silencing"},{"key":"10.1016\/j.vaccine.2016.09.009_b0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-3341-9_14","article-title":"A systems approach to understand antigen presentation and the immune response","volume":"1394","author":"Dudek","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0110","doi-asserted-by":"crossref","first-page":"e1003129","DOI":"10.1371\/journal.ppat.1003129","article-title":"Kinetics of antigen expression and epitope presentation during virus infection","volume":"9","author":"Croft","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.09.009_b0115","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1074\/mcp.T600050-MCP200","article-title":"The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra","volume":"6","author":"Shilov","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2016.09.009_b0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.09.009_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0719s47","article-title":"Generation and maintenance of cloned human T cell lines","author":"Yssel","year":"2002","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0091-679X(04)75020-7","article-title":"Detection of T-cell degranulation: CD107a and b","volume":"75","author":"Betts","year":"2004","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0135","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.009_b0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.009_b0145","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1084\/jem.145.5.1387","article-title":"Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products","volume":"145","author":"Billings","year":"1977","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.009_b0150","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.137.11.3639","article-title":"Features of target cell lysis by class I and class II MHC-restricted cytolytic T lymphocytes","volume":"137","author":"Maimone","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/308365a0","article-title":"Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture","volume":"308","author":"Fleischer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.09.009_b0160","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2016.09.009_b0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.immunol.26.021607.090404","article-title":"Death by a thousand cuts: granzyme pathways of programmed cell death","volume":"26","author":"Chowdhury","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0175","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/cdd.2009.206","article-title":"Granzymes in cancer and immunity","volume":"17","author":"Cullen","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.vaccine.2016.09.009_b0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.0105-2896.2010.00907.x","article-title":"Functional dissection of the granzyme family: cell death and inflammation","volume":"235","author":"Anthony","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.09.009_b0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.0105-2896.2010.00889.x","article-title":"Orphan granzymes find a home","volume":"235","author":"Bovenschen","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.09.009_b0190","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/JVI.02528-08","article-title":"Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure","volume":"83","author":"Harari","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0195","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1172\/JCI42758","article-title":"Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation","volume":"120","author":"Hertoghs","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.09.009_b0200","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/eji.200526122","article-title":"Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood","volume":"35","author":"Bratke","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic T lymphocytes: all roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.09.009_b0210","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.283.5408.1745","article-title":"Linear differentiation of cytotoxic effectors into memory T lymphocytes","volume":"283","author":"Opferman","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.09.009_b0215","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/21208","article-title":"Modelling T-cell memory by genetic marking of memory T cells in vivo","volume":"399","author":"Jacob","year":"1999","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16308052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16308052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:16:49Z","timestamp":1692490609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16308052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0264410X16308052"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}